Skip to main content
. 2017 Jan 31;15(1):68–74. doi: 10.5217/ir.2017.15.1.68

Table 1. Overview of Donor Screening Process.

Serological Stool Past history
HAV/IgM Fecal immunochemical test (twice) Antibiotic treatment during 1 month
HBsAg Clostridium difficile toxin A/B IBD, IBS, chronic constipation/diarrhea
Anti-HCV Culture for enteric pathogens Malignancy
Human immunodeficiency virus 1 and 2 enzyme immunoassay Ova and parasite examination Autoimmune or atopic illness or ongoing immune-modulating therapy
Antibody to Entamoeba histolytica Severe obesity
Rapid plasma regain Severe liver/kidney dysfunction